Clinical trial databases are sprouting like weeds, but do they provide the information the public needs? Aaron Bouchie investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Clinical Trials.gov. http://www.clinicaltrials.gov
FDA Modernization Act of 1997. http://www.fda.gov/cber/fdama.htm
De Angelis, C. et al. Ann. Intern. Med. 141, 477–478 (2004).
Sim, I. et al. The Lancet 367, 1631–1633 (2006).
Author information
Authors and Affiliations
Supplementary information
Supplementary Table 1
Databases of clinical data on marketed products. (DOC 28 kb)
Related links
Related links
Related links in Nature Research
Industry anger over stringent trial disclosure requirements
https://doi.org/10.1038/News@nature.com5April2006;|doi:10.1038/news060503-8
Calls for full disclosure of clinical trials
Web links
Rights and permissions
About this article
Cite this article
Bouchie, A. Clinical trial data: to disclose or not to disclose?. Nat Biotechnol 24, 1058–1060 (2006). https://doi.org/10.1038/nbt0906-1058
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0906-1058
This article is cited by
-
Clinical forecasting in drug development
Nature Reviews Drug Discovery (2007)
